Arthritis Pain Acetaminophen Tablet
Product Images NDC 11673-673

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Arthritis Pain Acetaminophen (NDC 11673-673). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Target Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

699r-target-ap-aceta-bottle-label-225s (699r Target Ap Aceta Bottle Label 225s)

699r-target-ap-aceta-bottle-label-225s (699r Target Ap Aceta Bottle Label 225s)
Arthritis Pain Acetaminophen extended-release tablets USP 650 mg in an oral tablet form. The label from Target Corporation states the package contains 225 capsule-shaped, bi-layer tablets. The label highlights it temporarily relieves minor arthritis pain for up to 8 hours and includes warnings and usage instructions. The label references comparison to Tylenol 8HR Arthritis Pain and cautions about tampering of the product seal.*
FDA Label Image

699r-target-ap-aceta-carton-label-225s (699r Target Ap Aceta Carton Label 225s)

699r-target-ap-aceta-carton-label-225s (699r Target Ap Aceta Carton Label 225s)
Carton label for Arthritis Pain Acetaminophen 650 mg extended-release tablets by Target Corporation. The label indicates 225 caplets, with dosage form as capsule-shaped bilayer tablets. The label includes Drug Facts panels detailing active ingredient, uses, warnings, directions, inactive ingredients, and contact information. The packaging features the Target up&up brand logo and NDC 11673-673-26.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.